FDA Inspection 1301040 - Regeneron Pharmaceuticals, Inc. - March 27, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Regeneron Pharmaceuticals, Inc., with an inspection on March 27, 2026, issued by the New York District Office, covering human drugs.

Company: Regeneron Pharmaceuticals, Inc.
Inspection Date: March 27, 2026
Product Type: Human Drugs
Office: New York District Office

Open in Dashboard

ID · 296ba636-d4d0-4d53-8759-4f578b9375a0